Market Place
Sourcing Support
All News #Library
Biotech
Mestag Therapeutics To Present Mst-0312 In Late-Breaking AACR
14 Apr 2026 //
GLOBENEWSWIRE
Mestag Pharma Secures $40M, Names CMO & CDO for Clinic Prep
17 Mar 2026 //
GLOBENEWSWIRE
Mestag to Present Data on Targeted LTBR Agonist MST-0312
12 Mar 2026 //
GLOBENEWSWIRE
Mestag Announces Licensing of Novel Inflammatory Disease Target
09 Dec 2024 //
GLOBENEWSWIRE
Mestag Therapeutics Expands Leadership & Appoints Key Roles
13 Nov 2024 //
GLOBENEWSWIRE
Merck signs $1.9B deal to explore fibroblast therapies
09 Oct 2024 //
FIERCE BIOTECH
Mestag Announces Collaboration With MSD For Inflammatory Diseases
08 Oct 2024 //
GLOBENEWSWIRE
Mestag Presents Preclinical Data at AACR of its M300 Program
08 Apr 2024 //
GLOBENEWSWIRE
Mestag Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
28 Feb 2024 //
GLOBENEWSWIRE
Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors
20 Feb 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.